Full Text View
Tabular View
Study Results
Related Studies
Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection
This study has been completed.
Study NCT00006178   Information provided by National Institutes of Health Clinical Center (CC)

First Received on August 15, 2000.   Last Updated on June 16, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Failure
Additional conditions recognized in this trial
Renal Insufficiency
More general conditions related to this trial
Kidney Diseases
Urologic Diseases
Interventions listed in this trial
Sirolimus
Thymoglobulin
Additional drug interventions recognized in this trial
Everolimus
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services